Clinical Trial Update: Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

View source ↗

Summary

A HepQuant, LLC trial is evaluating the HepQuant DuO Test as a biomarker for alcohol-related liver disease, including alcoholic hepatitis, and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-related Liver Disease
• Alcoholic Hepatitis

Snippet

Sponsor: HepQuant, LLC | Conditions: Alcoholic Hepatitis, Alcohol-related Liver Disease | Status: RECRUITING